| Mark H Stauffer, MD | |
|
3260 Hospital Dr, Juneau, AK 99801 | |
| (907) 796-8632 | |
| (907) 796-8455 |
| Full Name | Mark H Stauffer |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Child & Adolescent Psychiatry |
| Location | 3260 Hospital Dr, Juneau, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760492342 | NPI | - | NPPES |
| MD3513 | Medicaid | AK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0804X | Psychiatry & Neurology - Child & Adolescent Psychiatry | 2217 (Alaska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mark H Stauffer, MD 3260 Hospital Dr, Juneau, AK 99801 Ph: (907) 796-8498 | Mark H Stauffer, MD 3260 Hospital Dr, Juneau, AK 99801 Ph: (907) 796-8632 |
News Archive
When doctors can't find a diagnosis for patient's disease, they turn to genetic detectives. Equipped with genomic sequencing technologies available for less than 10 years, these sleuths now routinely search through a patient's DNA looking for mutations responsible for mysterious diseases.
The Obama administration released the final details Friday of the exemption it will provide religious-affiliated employers from the requirement to include free birth control in employees' insurance policies. Not surprisingly, the announcement didn't seem to mollify any of the critics who'd been arguing that the exemption was inadequate.
The past 25 years have seen a significant increase in student participation in high school athletics. Studies have revealed that 2 million injuries, 500,000 doctor visits and 30,000 hospitalizations occur each year among high school athletes.
NuPathe Inc., a specialty pharmaceutical company developing innovative products for the treatment of neurological and psychiatric diseases, today announced data from the pivotal Phase III trial of Zelrix™, a novel transdermal patch in clinical development for the treatment of acute migraine. Zelrix combines NuPathe's proprietary SmartRelief™ iontophoretic transdermal technology with sumatriptan, the most prescribed treatment for acute migraine in the United States.
Getting control of COVID-19 will take more than widespread vaccination; it will also require a better understanding of why the disease causes no apparent symptoms in some people but leads to rapid multi-organ failure and death in others, as well as better insight into what treatments work best and for which patients.
› Verified 3 days ago
Robert D Schults, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 3260 Hospital Dr, Juneau, AK 99801 Phone: 907-796-8498 Fax: 907-796-8497 | |
Dr. David Benjamin Robinson, M.D., M.P.H. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2239 Jordan Ave, Juneau, AK 99801 Phone: 907-789-3800 Fax: 907-789-2402 | |
Marie Roy Babbitt, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3240 Hospital Dr, Juneau, AK 99801 Phone: 907-796-8948 Fax: 907-796-8497 | |
Mr. Paul Jiri Topol, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2 Marine Way, Suite 204, Juneau, AK 99801 Phone: 907-209-8962 Fax: 866-581-8172 | |
Dr. Susan E Hunter-joerns, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2205 Jordan Ave, Juneau, AK 99801 Phone: 907-790-3224 Fax: 907-790-3226 | |
Dr. Eli Alexander Woods Oates, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3260 Hospital Dr, Juneau, AK 99801 Phone: 907-796-8900 | |
Alvin J Fineman, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3240 Hospital Dr, Juneau, AK 99801 Phone: 907-796-8498 Fax: 907-796-8497 |